dapagliflozin Articles
FDA’s CRL on dapagliflozin calls for more clinical data
19 January 2012
AstraZeneca and B-MS see delay for dapagliflozin, as AZ posts 3rd-qtr 2011 results with generics taking a toll
27 October 2011
US FDA advisory gives thumbs down to B-MS and AstraZeneca diabetes drug dapagliflozin on safety issues
20 July 2011
Bristol-Myers Squibb’s R&D pipeline boosted by diabetes drug dapagliflozin, say Zacks analysts
18 October 2010
Positive new data on diabetes drugs from Novo Nordisk, AstraZeneca/B-MS and Sanofi-Aventis presented at EASD meeting
21 September 2010
Showing 1-13 of 13 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
